Implantable medical devices development

At the dawn of the 21st century, the invention, development, and use of hiomaterials has become big business in the United States and around the world. According to a 2001 report in Chemical and Engineering News, more than 10 million Americans now have at least one kind of implanted medical device, and national sales generated by the hiomaterials industry exceeds 50 billion per year. Industry analysts see an even larger future for the industry. For example, every year about 30,000 people die from liver failure while waiting for liver transplants, of which fewer than 3,000 become available every year. Modifications that would lead to acceptable liver substitutes would save the lives of many of these individuals. 

PHB (polyhydroxybutyrate) Pseudomonas pseudomallei Development of implanted medical devices for dental, craniomaxillofacial, orthopaedic, hernioplastic and skin surgery. 

The perspective area of PHB application is the development of implanted medical devices for dental, cranio-maxillofacial, orthopedic, cardiovascu-... 

The development of primary lithium batteries for implantable medical devices was a big advance that enabled devices to operate more reliably and longer. Lithium is the lightest metal and has the most negative reduction potential. When combined with any number of positive electrode materials, the result is cells with high energy densities compared to aqueous cells. Most lithium cells have an initial open circuit voltage between 1.8 and 3.9 V, compared to 1.2-1.6 V for most aqueous cells. 

The chemistry systems in the Li ion cells that are manufactured specifically for implantable medical devices are similar to those developed for consumer applications. 

Developers of secondary cells for implantable medical devices must consider the possibility of what happens when the battery is not charged for whatever reason in a timely fashion. If the cell becomes over discharged and its voltage is allowed to go below a certain threshold, the cell may not fuUy recover once it is charged and performance may be reduced. 

Additionally, there are many emerging indications for wearable or implantable medical devices, particularly new neuromodulation applications such as deep brain stimulation for various movement and neurological disorders [57] and occipital nerve stimulation to treat migraine and cluster headaches [58]. Implantable visual prostheses to restore sight are also under development. 

The importance of these three scale levels has been progressively pointed out as the fibrous implantable medical devices area evolves. Vascular prostheses evolution is a representative example. These medical devices developed in the 1950s, and since have improved a great deal. Currently, there are still weaknesses in vascular prostheses and research studies are still undergoing to overcome them. 

Without question, advances in telephony will continue. As more and more people move from wired to wireless communications, transmission techniques will be developed to allow higher speed communications. Applications for handheld devices, or apps, proliferate and are even being developed by high school students. Smart devices are likely to be installed in the home and even in the human body. By dialing a preprogrammed number, people will be able to change the temperature in the house, the voltage applied by an implanted medical device, or the way money is transferred from one bank to another. The possibilities are endless. 

In this book, a few applications of responsive materials and surfaces are explored, which include cell culture and tissue engineering (Chapter 9), drug delivery and diagnostic systems (Chapter 10), implantable medical devices and biosensors (Chapter 11). These areas were chosen not only because they have huge economic value, but also involve challenges during the development toward applications. 

Systemic antibiotic treatment is a very common medical procedure all over the world. Nevertheless, it presents certain limitations and drawbacks, such as systemic toxicity, poor penetration in certain tissues, and poor control of local drug levels. Additionally, in the case of implantable medical devices, if bacteria (typically 5. aureus, S. epider-midis. Pseudomonas aeruginosa, E. colt, etc. ) adhere and proliferate, colonizing the implant surface and forming a biofilm, the patient may develop an infection despite systemic antibiotic treatment, which may lead to the rejection or removal of the implant (Fig. 10). Actually, an implant represents a challenge to the immune system. 

In the opinion of material scientists, thin-film technology is essential in the development of rechargeable hthium-based microbatteries for potential applications, such as smart cards, nonvolatile memory backup devices, MEMS sensors and actuators, and miniaturized implantable medical devices. Battery designers predict that for such applications film thickness should not exceed a few tens of micrometers or microns (10 cm). This means that the film thickness must be at least ten micrometers or 0.001 cm (0.0025 in.), which may be suitable for minimum battery... 

Many issues associated with hermetic packaging have yet to be completely understood, let alone overcome. The continued miniaturization of future implantable medical devices provides both opportunities and challenges for packaging/materials engineers to improve the current packaging methods and to develop new methods. Reliable hermetic micropackaging technologies are the key to a wide utilization of MEMS in miniaturized implantable medical devices. 

---